Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

83.62 -0.40 (-0.48%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Silk Road Medical Announces Definitive Agreement to be Acquired by Boston Scientific
From Silk Road Medical
Via GlobeNewswire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention. 
Via Benzinga
Check Out What Whales Are Doing With BSX
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Here's How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years
Via Benzinga
How Is The Market Feeling About Boston Scientific?
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today
Via Benzinga
Decoding 18 Analyst Evaluations For Boston Scientific
Via Benzinga
Jim Cramer Recommends Buying This Sports Betting Company's Stock: 'I Think It's Terrific'
Sports betting app DraftKings is "terrific," Cramer says. The company recently reported Q1 revenue of $1.18 billion, up 53% year-over-year. 
Via Benzinga
Boston Scientific's Upside With Cardiology Devices Drives Momentum
Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoption and Watchman FLX upside driving momentum. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
MarketBeat Week in Review – 4/29 - 5/3
Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024 
Via MarketBeat
Topics Economy Stocks
Exposures Interest Rates US Equities
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
Via Benzinga
Topics Stocks
Exposures US Equities
(BSX) - Analyzing Boston Scientific's Short Interest
Via Benzinga
Citi Just Raised Its Price Target on These 3 Stocks
Discover the three stocks enjoying boosted Citi price targets. Analysts believe they are primed for success, so it's time to start buying. 
Via InvestorPlace
Needham Just Boosted Its Price Target on These 3 Stocks
Amidst the uncertainty in the market at this time, it is best to rely on Needham price targets to make informed decisions. 
Via InvestorPlace
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
Via MarketBeat
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser. 
Via Investor's Business Daily
Key Takeaways From Boston Scientific Analyst Ratings
Via Benzinga
Top 4 Health Care Stocks That May Plunge This Month
Via Benzinga
Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier. 
Via Investor's Business Daily
Wabtec Rumbles onto Stock Spotlight List. Check These Lists For Best Stocks To Watch And Buy
Wabtec leads a diverse group climbing aboard the Stock Spotlight list, including defense and aerospace play TransDigm. 
Via Investor's Business Daily
Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars
Boston Scientific reports impressive Q1 earnings, with revenues of $3.86 billion, beating estimates. Cardiovascular segment leads with $2.4 billion sales, up 15.9%. Outlook: 2024 net sales growth... 
Via Benzinga
Hilton Worldwide Reports Upbeat Results, Joins Hasbro, Vertiv Holdings And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
BSX Stock Earnings: Boston Scientific Beats EPS, Beats Revenue for Q1 2024
BSX stock results show that Boston Scientific beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Boston Scientific Pops Into Buy Zones On Solid First-Quarter Report
Boston Scientific heads for two different buy zones after topping Q1 views and hoisting guidance above expectations. 
Via Investor's Business Daily
Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?
Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the... 
Via Benzinga
Topics Bonds
Exposures Debt Markets
Nasdaq Futures Get A Lift From Tesla, Texas Instruments Earnings: Analyst Points To Key Catalyst For Boosting Rally
Nasdaq and S&P 500 futures signaled a higher open on Wednesday, thanks to upbeat guidance from EV giant Tesla, Inc. (NASDAQ:TSLA) and semiconductor m 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.